Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
455
-
Total 13F shares, excl. options
-
92,503,328
-
Shares change
-
+2,164,289
-
Total reported value, excl. options
-
$9,581,445,253
-
Value change
-
+$226,242,346
-
Put/Call ratio
-
1.85%
-
Number of buys
-
222
-
Number of sells
-
-185
-
Price
-
$103.58
Significant Holders of RESMED INC - Common Stock (RMD) as of Q2 2018
513 filings reported holding RMD - RESMED INC - Common Stock as of Q2 2018.
RESMED INC - Common Stock (RMD) has 455 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92,503,328 shares
of 146,467,184 outstanding shares and own 63.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14,498,676 shares), Capital World Investors (11,552,074 shares), BlackRock Inc. (10,953,800 shares), FMR LLC (8,072,299 shares), STATE STREET CORP (5,517,084 shares), BAILLIE GIFFORD & CO (4,826,851 shares), GEODE CAPITAL MANAGEMENT, LLC (1,761,999 shares), NORTHERN TRUST CORP (1,634,954 shares), Bank of New York Mellon Corp (1,620,844 shares), and JPMORGAN CHASE & CO (1,345,135 shares).
This table shows the top 455 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.